Ensysce Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · La Jolla, CA
ENSC chart
What traders are saying about $ENSC
Latest postsEnsysce Biosciences, Inc. news
- Ensysce Biosciences (ENSC) Gains 4.29% to $0.52 as Shares Press Toward Resistance - Andrews Pitchfork
https://www.siam.in/ ·
- Ensysce Biosciences participates in Family Office Summit, Dubai
TipRanks ·
- Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai
Yahoo Finance ·
- Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA
Yahoo Finance ·
- Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation
Yahoo Finance ·
- Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
Yahoo Finance ·
- Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
Yahoo Finance ·
- Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study
Yahoo Finance ·
- Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium
Yahoo Finance ·
- ENSC Sets Itself Up Nicely for Critical Stage
Yahoo Finance ·
- Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Yahoo Finance ·
- Ensysce Biosciences Completes Cy Biopharma Acquisition and Secures Up to $77 Million Private Financing
investorshub.advfn.com ·
Ensysce Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $5.1M | $5.2M | $2.2M | $2.5M |
| Net income | – | – | – | – |
| Diluted EPS | $-3.98 | $-11.45 | $-70.40 | $-139.42 |
| Total assets (year end) | $7.5M | $5.6M | $2.7M | $5.9M |
| Cash and equivalents (year end) | $4.3M | $3.5M | $1.1M | $3.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Ensysce Biosciences, Inc.
- Ticker
- ENSC (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- La Jolla, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1716947
- Former names
- Leisure Acquisition Corp.
Frequently asked questions
What exchange is Ensysce Biosciences, Inc. listed on?
Ensysce Biosciences, Inc. trades on the Nasdaq under the ticker symbol ENSC.
What industry is Ensysce Biosciences, Inc. in?
Ensysce Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Ensysce Biosciences, Inc. headquartered?
Ensysce Biosciences, Inc.'s business address on file with the SEC is in La Jolla, CA.
When does Ensysce Biosciences, Inc.'s fiscal year end?
Ensysce Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Ensysce Biosciences, Inc. report?
Ensysce Biosciences, Inc. reported $5.1M in revenue for calendar year 2025, according to its SEC filings.